在患有克罗恩氏病和性结肠炎的患者中评估度
Michał Chalcarz1,2, Beniamin Oskar Grabarek2, Tomasz Sirek3,4
1Chalcarz Clinic, 60-567 Poznań, Poland.
Biomedicines
|October 26, 2024
概括
克罗恩病 (CD) 和性结肠炎 (UC) 患者的血清水平较低,这表明缺乏可能表明炎症性肠病 (IBD) 的严重程度.
科学领域:
- 生物化学 生物化学
- 临床医学 临床医学
- 营养科学 营养科学
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),影响着大量的人口.
- IBD患者的区域状况,特别是在波兰人口统计学中,是一个研究不足的领域.
- 确定IBD活动的非侵入性生物标志物对于患者管理至关重要.
研究的目的:
- 在CD和UC患者中评估血清水平.
- 为了确定血清水平是否可以作为IBD疾病活动的预测标志物.
- 调查波兰人口中状况和IBD之间的关系.
主要方法:
- 血清的度使用诱导合血质谱法 (ICP-MS) 量化.
- 该研究包括100名IBD患者 (54名CD,46名UC) 和100名健康对照.
- 用回归分析来确定水平的预测因素.
主要成果:
- 与健康对照组相比,患有CD和UC的患者的血清水平显著降低 (p < 0.0001).
- 白细胞计数,红细胞计数和胆红素被确定为UC患者水平的显著预测因素.
- 在CD患者中没有发现水平的显著预测因子.
结论:
- 缺乏与IBD有关,可能作为疾病严重程度的非侵入性生物标志物,特别是在UC.
- 血清水平为监测IBD进展提供了内镜手术的潜在非侵入性替代方案.
- 需要在更大的队列中进行进一步的研究来验证这些发现,并探索补充剂在IBD中的治疗潜力.
更多相关视频
09:42Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
18.6K
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
12.2K
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
322
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
322
01:30Inflammatory Bowel Disease II: Crohn's Disease
189
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
189
01:30Serum Laboratory Studies, Stool Test, Breath Test
317
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
317
01:29Drugs for Treatment of Ulcerative Colitis in IBD
124
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
124
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
146
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
146